Aligos Therapeutics, Inc.: Form 8-K, filed May 31, 2024
Filed with the SEC on May 31, 2024 and accepted by EDGAR at May 31, 2024, 16:05 ET.
Items reported
- Item 3.01 Delisting notice
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-24-151729. Last ingested by Listed: Nov 14, 2026, 12:59 ET. Listed shows no prices and gives no investment advice.